News

Oxford & AstraZeneca Covid-19 vaccine up to 90% effective, data shows

Preliminary results from an interim analysis of clinical trials of the ChAdOx1 nCoV-19 candidate show the vaccine is on average 70.4% effective at preventing Covid-19. Data was taken from two dosing regimes, which show that the vaccine is 90%...

Chinese company seeks permission to launch covid vaccine for public use

A leading Chinese vaccine developer has applied for authorization to bring its Covid-19 shot to the market, seeking to get a jump on Western rivals as the race for a working inoculation against the virus enters the final stretch. China...

Nearly a million receive injection of Sinopharm-developed vaccine, no serious adverse reactions

Vaccines developed by Chinese pharmaceutical company Sinopharm Group have now been used on nearly one million people, with no serious adverse reactions reported, and only a few people reporting mild symptoms, Sinopharm Chairman Liu Jingzhen told Chinese media. The vaccines'...

Mexico aims to begin coronavirus vaccinations next month

Mexico said that it aims to start coronavirus vaccinations next month in the Latin American country, which has one of the world's highest COVID-19 death tolls. The government has signed deals with major pharmaceutical companies, including Pfizer, which with its...

US will distribute 6.4 million COVID-19 vaccine doses in first tranche

The US plans to distribute 6.4 million doses of the Pfizer-BioNTech COVID-19 vaccine in the first week after it is cleared for emergency use, which is likely next month, officials said. A committee of the Food and Drug Administration meets...

EU Reaches Deal For Supply Of 160 Million Doses Of Moderna COVID-19 Vaccine

The European Union on Tuesday has reached a deal with drugmaker Moderna for the supply of its experimental coronavirus vaccine candidate, the head of the European Commission said. "I am happy to announce that tomorrow we will approve a new...

Pfizer, Moderna Boost Hopes But Many Nations Counting On Oxford Vaccine

Trial successes from Pfizer Inc. and Moderna Inc. have buoyed hopes that a Covid-19 vaccine is coming soon. But much of the world, outside of rich nations like the U.S., is counting on another company's shot to escape the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read